| Role |
Name |
Disclosure |
Details |
| Author | Roy Sucholeiki, MD, Director, Comprehensive Seizure and Epilepsy Program, The Neurosciences Institute at Central DuPage Hospital | UCB Pharma | Details | | Coauthor | Sydney Louis, MD, Emeritus Professor, Department of Neurology, Brown University School of Medicine | Nothing to disclose | Details | | Medical Editor | Joseph F Hulihan, MD, Vice President, Medical Affairs, Ortho-McNeil Janssen Scientific Affairs, LLC | Johnson & Johnson Johnson & Johnson | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Norberto Alvarez, MD, Assistant Professor, Department of Neurology, Harvard Medical School; Consulting Staff, Department of Neurology, Boston Children's Hospital | Nothing to disclose | Details | | CME Editor | Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital | Nothing to disclose | Details | | Chief Editor | Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Sydney Louis, Coauthor |
The contributor discloses no conflict of interest. |
|